Frequently asked questions about law enforcement in health care settings.

Shine Bright for Kids: How community support fuels groundbreaking care at Children’s Minnesota

September is Childhood Cancer and Sickle Cell Awareness Month and it’s a time to raise awareness and funds for the vital work being done to help children facing these illnesses. As the largest program of its kind in the state, Children’s Minnesota’s cancer and blood disorders program cares for about 3,500 patients each year.

While the program is known for its advanced treatments and groundbreaking research, it’s the passion of the entire team — from doctors and nurses to child life specialists and social workers — that truly makes the difference. They show up every day, committed to caring for kids and supporting families during their most challenging moments. 

But their work is not done alone. The community’s generosity fuels innovation that is shaping the future of treatment. 

Leading research and clinical trials

Red-light therapy

A Children’s Minnesota nurse is studying a groundbreaking way to prevent painful mouth sores caused by cancer treatment. By using red-light therapy, her work is helping to ease pain, lower infection risk, and reduce hospital stays. The team is now studying a portable, at-home device to make this treatment more accessible for patients. 

Bone health

Survivors of pediatric high-risk leukemia often face long-term bone health challenges, including weakness, decreased bone density, and structural damage, which can significantly impact their quality of life. These effects stem not only from the disease itself but also from intensive treatments such as chemotherapy, radiation, and stem cell transplants that disrupt bone growth and mineralization during critical developmental years. Research is underway to assess bone density and quality of life in leukemia survivors with the aim to improve and protect long-term bone function and quality of life.  

Brain tumor vaccine

Children’s Minnesota is the only hospital in the nation leading a Phase 1 clinical trial for children with diffuse midline glioma, an aggressive and devastating brain cancer. This trial uses a new combination of a vaccine, a synthetic peptide, and radiation to help the body fight the tumor. This represents a critical step forward in developing new therapies for a disease that has long had limited treatment options. 

The impact of your support

Thanks to the generosity of our fundraisers and donor community, we marked raising over $300,000 at the Shine Bright celebration on Sept. 30th. Their support reminds our staff that an entire community stands behind them.

More news stories

Creating a better emergency care experience: Children’s Minnesota emergency department awarded for excellence
Children’s Minnesota’s Minneapolis emergency department renovation, designed to reduce wait times and improve the patient care experience, has been recognized by Finance & Commerce and Minnesota Physician....
Children’s Minnesota earns Silver award for Best Pediatrics in Star Tribune’s Minnesota’s Best contest
Children’s Minnesota is proud to share that it has earned a Silver award in the Best Pediatrics category in the Minnesota Star Tribune’s Minnesota’s Best 2026 best-of contest....
Heart murmur in kids: causes, symptoms and when to worry
Learn about heart murmurs in kids, common causes, symptoms, diagnosis, and when to seek medical attention from the cardiovascular experts at Children’s Minnesota....
Give to Kids Day

Today is Give to Kids Day!

A day for our generous community to join together to ensure that even the tiniest hearts get the strongest possible start.